cprx: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by (used in) financing activities	8,586	3,932
Net increase (decrease) in cash and cash equivalents	172,339	135,247
Cash and cash equivalents at beginning of period	517,553	-
Cash and cash equivalents at end of period	689,892	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by (used in) financing activities	8,586	3,932
Net increase (decrease) in cash and cash equivalents	172,339	135,247
Cash and cash equivalents at beginning of period	517,553	-
Cash and cash equivalents at end of period	689,892	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

CATALYST PHARMACEUTICALS, INC. (CPRX)